Filing Flows › Strata Critical Medical (SRTA) › Q2 2026 › vs Q2 2025
Strata Critical Medical (SRTA) Q2 2026 vs Q2 2025 (year over year)
Strata Critical Medical's revenue rose $27.4M (+61%) from $45.1M in Q2 2025 to $72.5M in Q2 2026. The biggest changes: Clinical +$24.3M (—); Logistics +$3.1M (+7%).
Strata Critical Medical, Q2 2026: revenue $72.5M (+61% year over year), operating margin -7.5%, net loss $10.5M, operating cash flow $5.7M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Logistics | $48.2M | $45.1M | $3.1M | +7% |
| Clinical | $24.3M | $0 | $24.3M | — |
| Revenue | $72.5M | $45.1M | $27.4M | +61% |
| Net loss | $10.5M | $3.7M | $6.8M | +181% |
| Costs & expenses | $83.0M | $49.7M | $33.3M | +67% |
| Operating costs | $77.9M | $49.7M | $28.2M | +57% |
| Interest & other, net | $5.1M | −$898K | $6.0M | — |
| Cost of revenue | $57.3M | $36.1M | $21.2M | +59% |
| SG&A | $14.0M | $13.3M | $704K | +5% |
| Other operating costs | $6.6M | $356K | $6.3M | 19× |
| Operating cash sources | $16.2M | $679K | $15.5M | 24× |
| Depreciation & amortization | $8.5M | $1.8M | $6.7M | +379% |
| Share-based compensation | $3.7M | $5.3M | −$1.6M | -31% |
| Working capital & other | $4.0M | −$6.4M | $10.4M | — |
| Net loss absorbed | $10.5M | $3.7M | $6.8M | +181% |
| Operating cash flow | $5.7M | −$3.1M | $8.8M | — |
Questions
How much did Strata Critical Medical's revenue grow year over year in Q2 2026?
Strata Critical Medical's revenue rose $27.4M (+61%) from $45.1M in Q2 2025 to $72.5M in Q2 2026.
What drove Strata Critical Medical's revenue change in Q2 2026?
Clinical +$24.3M (—); Logistics +$3.1M (+7%).